mechanism responsible for this phenomenon is thought to be an immunological deficit, 1 0 0
Parasitic strongylid nematodes have a number of genetic features, which favour the 1 0 1 development of anthelmintic resistance, such as rapid rates of nucleotide sequence 1 0 2 evolution and exceedingly large effective population sizes, leading to remarkably high 1 0 3 levels of genetic diversity (Blouin et al., 1995; Gilleard and Redman, 2016) . A. caninum is 1 0 4 the most common nematode parasite of greyhounds on breeding farms (Ridley et al., 1994) ; 1 0 5 this high prevalence is likely a consequence of the unrestricted access to exercise runs made 1 0 6 out of sand and dirt, which produces an ideal environment for the development and survival 1 0 7 of the infective larvae (Bowman, 2014) . To address the problem of nematode infections, the 1 0 8 dogs on these breeding farms are subject to a very intense deworming protocol; puppies are 1 0 9 often treated weekly with an anthelmintic until three months of age, then tri-weekly until 1 1 0 sixth months of age, and then monthly for the rest of their breeding or racing lives (Ridley 1 1 1 et al., 1994) . This would present a very high drug selection pressure on the hookworm 1 1 2 population on these farms and racing kennels. In livestock, the intensive use and near complete reliance on anthelmintic drugs for 1 1 4 control of nematode infections has led to high levels of anthelmintic resistance and multi-1 1 5 drug resistant (MDR) populations of nematodes on a global scale (Kaplan, 2004) . In 1 1 6 contrast, anthelmintic resistance in nematode parasites of dogs has developed much more 1 1 7 slowly, with few cases reported, and until now, only to pyrantel. The first report of 1 1 8 pyrantel resistance was from New Zealand in a greyhound puppy that was imported from 1 1 9
Australia (Jackson et al., 1987) , with several more cases subsequently diagnosed in Australia (Hopkins, 1991 (Hopkins, , 1989 Kopp et al., 2008a Kopp et al., , 2008b Kopp et al., 2007) . The issue of 1 2 1 whether resistance is likely to become a problem in parasites of dogs has received relatively 1 2 2 little attention, and when addressed, it has been viewed as an issue relating to the increased 1 2 3 use of prophylactic helminth treatments in pets (Thompson, 2001) . However, the 1 2 4 epidemiology of nematode transmission on greyhound farms much more closely resembles anthelmintic resistance also were to become a common problem on greyhound farms. Interestingly, coincident with our investigations, a recent publication reported resistance to 1 2 9 benzimidazoles and macrocyclic lactones in an isolate of A. caninum. The parasite isolate 1 3 0 in that report was originally obtained from a greyhound dog in Florida with a history of 1 3 1 monthly heartworm preventive treatment (product/drug not specified) that presented to a 1 3 2 veterinary clinic with a hookworm infection that was refractory to multiple treatments with Beyond the concerns for canine health, multiple-drug resistance in canine 1 3 5 hookworms would present serious public health concerns, since A. caninum is zoonotic; 1 3 6 humans infected percutaneously may develop cutaneous larva migrans (CLM) (Leeming, 1 3 7 1966), a linear, circuitous, erythematous and intensely pruritic eruption of the skin caused 1 3 8 by migration of the hookworm larvae. Previously, cases of CLM could be treated fairly 1 3 9 easily using topical anthelmintics (Heukelbach and Feldmeier, 2008) ; however, such 1 4 0 treatments will not be effective against MDR worms. Cases of eosinophilic enteritis 1 4 1 (Prociv and Croese, 1996) , as well as patent infections have also been described Given the increasing frequency of reports by veterinarians of recurrent hookworm 1 4 4 infections that are poorly responsive to anthelmintics, it seemed likely that anthelmintic 1 4 5 resistance had evolved in A. caninum. The aim of this study was to characterize several of 1 4 6 these suspected resistant isolates using in vitro, genetic, and clinical testing to determine if 1 4 7 these cases represent true anthelmintic resistance in A. caninum. Three fecal samples containing hookworm eggs were received from veterinarians 1 5 2 who were treating cases of recurrent hookworm infections in canine patients. These three 1 5 3 "suspected-resistant" isolates of A. caninum were designated Worthy, Lacy and Tara. Two 1 5 4 additional fecal samples from drug-susceptible A. caninum isolates were also received. One designated ETCR, was previously cycled in the laboratory and confirmed as 1 5 6 susceptible, and a second was acquired from a local dog shelter. For the experimental 1 5 7 infections, eggs recovered from fecal samples were placed onto NGM plates (Sulston and 1 5 8 response and a RR of 69.8, which was quite similar to the RR for the macrocyclic lactones 4 0 0 in the earlier assays ( Fig. 3 , Table 3 ). below the 95% thresholds typically used for declaring resistance (Coles et al., 1992) , with 4 0 5 the exception of fenbendazole at day 10 ( Fig 4, Table 4 ). It is also noteworthy, that by the 4 0 6 time the dogs were treated with milbemycin oxime, the EPG of the dogs were in a steep 4 0 7 natural decline due to the senescence of the infections. Thus, the measured levels of FECR 4 0 8 are likely considerably higher than the true values. Still, these values were below 95%. ranging from 13% to almost 100% (Table 5 ). In the samples from the susceptible isolates, 4 1 9
the allele frequencies were 0%, 1% and 9% ( lives (Ridley et al., 1994) . The intervals between these treatments often are less than the 4 3 9
pre-patent period for hookworms. This high intensity of treatment will minimize the 4 4 0 amount of refugia (parasite life stages that are not exposed to anthelmintic treatment), thus The LDA is a commonly used in vitro bioassay used for detecting resistance to sheep and goats (Howell et al., 2008; Kaplan et al., 2007; Raza et al., 2016) and swine 4 7 0 (Varady et al., 1996) . The LDA is based on the ability of anthelmintics to prevent free- LDA appears only useful for measuring resistance to macrocyclic lactone drugs. This resistant isolates (Craven et al., 1999; Tandon and Kaplan, 2004; Varady et al., 1996) . Interestingly, we found a wide range in the level of resistance in the two resistant 4 8 5
isolates we tested, and those differences seem to correlate with the clinical case histories of a RR of 63.2, which is more than 11 times greater than the RR of 5.5 that we measured for 4 8 8
Lacy. As noted in the clinical case histories, there was no history of recent use of best of our knowledge, greyhound farms and kennels have been administering ivermectin 4 9 5
for parasite control for decades, but did not begin using moxidectin until very recently. Thus, it is unlikely that any of the dogs infected with the resistant isolates evaluated in this 4 9 7 study were treated with moxidectin prior to adoption. Second, moxidectin is considerably 4 9 8 more potent than ivermectin against many nematodes. In H. contortus, ivermectin resistant 4 9 9
worms that are naïve to moxidectin are killed at very high efficacy following administration 5 0 0 of moxidectin (Craig et al., 1992; Oosthuizen and Erasmus, 1993) ; however, once found that a farm naïve to moxidectin but with ivermectin resistance had an LDA RR of suggest that the resistant hookworms originating with the greyhounds and now spreading 5 0 7
into the pet population have a clinically relevant level of resistance to macrocyclic lactones 5 0 8 even without further selection, such as those infecting Lacy. However, as evidenced by the 5 0 9
data from Worthy, additional selection with moxidectin can rapidly lead to very high levels 5 1 0 of field-derived resistance.
1 1
The other recent report of resistance in A. caninum (Kitchen et al., 2019) than 80% was not achieved, and shapes of dose response curves were not sigmoidal. The cause of these differences is not readily apparent, but likely are due to differences in the 5 2 9 methods used in the two studies. initially decreased by greater than 99%, but then steadily increased after treatment, resistance in the surviving worms, the egg count and clinical response data suggest that the 5 3 8 treatment was poorly effective in killing the worms, but induced a temporary inhibition of 5 3 9 egg production. A similar temporary deleterious effect on worm fecundity has been Regarding the reductions in FEC measured for pyrantel and milbemycin oxime, the 5 4 6
decreasing pattern of the FEC from the two dogs used to passage the Tara and Worthy worms due to senescence was already occurring by the time pyrantel and milbemycin 5 4 9 oxime were administered. By the time the dogs were treated with pyrantel, the infections 5 5 0
were 66 days old, and we have found that experimentally infected dogs tend to demonstrate 5 5 1 large reductions in FEC by around 52 days post-infection. However, even with this natural 5 5 2 reduction in FEC, which would bias the results toward higher efficacy, the reduction for 5 5 3 both these treatments were less than 90% and in one case as low as 0%.
4
Currently, the mechanisms of resistance to macrocyclic lactones and pyrantel in detect resistance to these drug classes. However, the mechanism of resistance to 5 5 7
benzimidazole drugs is well-described. Benzimidazoles work by blocking the 5 5 8
polymerization of parasite microtubules, and they do this by binding to the nematode β -
tubulin protein monomers (Lacey, 1988 (Lacey, , 1990 However, a recently developed deep-amplicon sequencing assay for measuring al., 2019). We modified and used this deep amplicon-sequencing assay for use with A. caninum and here we report the first use of this approach in a hookworm. Of the single reported in a resistant isolate of A. caninum that was originally isolated from a racing 5 8 3 greyhound from Florida. Furthermore, using CRISPR/Cas 9, they were successful in 5 8 4
replicating this single nucleotide polymorphism in the homologous ben-1 gene of C. Using deep amplicon sequencing, we found low allele frequencies for the 5 8 8
benzimidazole resistance-associated single nucleotide polymorphisms in the susceptible 5 8 9
isolates; in Barrow, the frequency was 1.2%, and the two analyses for ETCR yielded highly 5 9 0 variable results of 0% and 8.8%. The reason for this discrepancy is not known and further 5 9 1
analyses are in progress. In contrast, high single nucleotide polymorphism frequencies were 5 9 2 recorded for all resistant isolates. The lowest frequency measured in a resistant isolate was 5 9 3
12.7% in Tara, however, following a single treatment with fenbendazole, the single 5 9 4
nucleotide polymorphism frequency increased to 50.9%. Interestingly, three single adult 5 9 5
worms recovered from the feces of Lacy that we sequenced (out of many that were expelled 5 9 6
alive after treatment with fenbendazole) had F167Y (TTC>TAC) single nucleotide 5 9 7
polymorphism frequencies of approximately 50% indicating that these worms were 5 9 8
heterozygous at codon 167. This was an interesting finding, as it suggests that heterozygous 5 9 9
worms were able to survive the treatment, but could not maintain their position in the GI In conclusion, MDR in A. caninum is an emerging problem in dogs. Evidence suggests that the problem originated in the greyhound racing industry and has since begun 6 2 8
to spread through the pet population. Clearly, further epidemiological and molecular Necator americanus. Consequently, these findings should provide some concern to the 6 3 6
global health community, as the scale-up of mass drug administration for soil-transmitted 
